May 7 – 12, 2023
Venice, Italy
Europe/Zurich timezone

CERN-MEDICIS: Operational indicators to support the production of new medical radionuclides by mass separation

WEPM125
May 10, 2023, 4:30 PM
2h
Sala Mosaici 2

Sala Mosaici 2

Poster Presentation MC7.T21: Infrastructures Wednesday Poster Session

Speakers

Charlotte Duchemin (European Organization for Nuclear Research) Thierry Stora (European Organization for Nuclear Research)

Description

CERN-MEDICIS is an isotope mass separation facility for biomedical R&D located in a class A laboratory, receiving up to 50% of the 1.4GeV PSB protons. It was commissioned with radioactive ion beams in 2017. MEDICIS has operated for the past 5 years in batch mode, with targets irradiated in a dedicated beam dump station at HRS, and with external sources provided by cyclotrons and nuclear reactors MEDICIS partners, notably during Long Shutdown LS2 [1,2]. Recent additions to the CERN-MEDICIS facility are the MELISSA laser ion source, radiochemistry on implanted isotopes, and online gamma implantation monitoring.

In 2022, we introduced key performance indicators (KPI’s) to monitor the facility for collected efficiencies, the optimization of the radiological risks and impact of modifications of the irradiation station, like the yearly integrated luminosity serves as one of the KPI's for LHC. Defined KPI’s cover different aspects in the operation cycle, such as planning in CERN schedule, target irradiations, process duration, radiological risk mitigation, facility downtime, developments and maintenance. MEDICIS KPI’s can help distinguish which of the elements in the operation and in the facility life-cycle thus requires immediate intervention, developments or consolidation.

Those deal with the irradiation stations, beam-lines (parallel collections), target and ion sources (reliability), robot handling and infrastructure, or the separation process itself.

Funding Agency

European Union’s H2020 PRISMAP project No 101008571

Footnotes

[1] R. Augusto et al., Appl. Sciences 4.2 (2014), 265.
[2] T. Stora et al. eds. (2022). MEDICIS-Promed:Advances in Radioactive Ion Beams for Nuclear Medicine. Frontiers doi:10.3389/978-2-83250-522-9

I have read and accept the Privacy Policy Statement Yes

Primary author

Thierry Stora (European Organization for Nuclear Research)

Co-authors

Alexandre Dorsival (European Organization for Nuclear Research) Alexandros Koliatos (European Organization for Nuclear Research) Bruce Marsh (European Organization for Nuclear Research) Charlotte Duchemin (European Organization for Nuclear Research) Christophe Mitifiot (European Organization for Nuclear Research) Elodie Aubert (European Organization for Nuclear Research) Fabio Pozzi (European Organization for Nuclear Research) Jean-Louis Grenard (European Organization for Nuclear Research) Joachim Vollaire (European Organization for Nuclear Research) Jose Ferreira Somoza (European Organization for Nuclear Research) Jose Rodriguez (European Organization for Nuclear Research) Laura Lambert (European Organization for Nuclear Research) Markus Widorski (European Organization for Nuclear Research) Matthieu Deschamps (European Organization for Nuclear Research) Michel Duraffourg (European Organization for Nuclear Research) Ralf Rossel (European Organization for Nuclear Research) Reinhard Heinke (Katholieke Universiteit Leuven) Sebastian Rothe (European Organization for Nuclear Research) Simone Gilardoni (European Organization for Nuclear Research) Slavka Prvakova (European Organization for Nuclear Research) Stefan Roesler (European Organization for Nuclear Research) Stefano Marzari (European Organization for Nuclear Research) Thomas Cocolios (Katholieke Universiteit Leuven) Valentin Fedosseev (European Organization for Nuclear Research) William Andreazza (European Organization for Nuclear Research)

Presentation materials

There are no materials yet.